4DMedical Ltd.ASX: 4DX

4DMedical receives FDA clearance for CTVQ

· Issued by 4DMedical Ltd.

Filed with ASX · · 4 pages · English

Summary by 6ix AI

4DMedical Ltd. has received FDA clearance for its CT:VQ™ product, marking a significant advancement in respiratory diagnostics. This technology is the first non-contrast imaging modality capable of providing quantitative ventilation and perfusion analysis from standard chest CT scans. The company anticipates capturing a substantial share of the market for ventilation-perfusion scans, which is currently dominated by nuclear imaging techniques.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

4DMedical Ltd. on 6ix

Story so far

Earlier from 4DMedical

Later from 4DMedical

All 4DMedical news releases